A Case of Electronic Nicotine Delivery Systems (ENDS) Liver Injury
Michelle Godbee, Shriram Jakate, Sheila Eswaran – 21 July 2020
Long‐Term Perfusion of the Liver Outside the Body: Warming Up for Ex Vivo Therapies?
- Read more about Long‐Term Perfusion of the Liver Outside the Body: Warming Up for Ex Vivo Therapies?
Ivo J. Schurink, Jorke Willemse, Monique M.A. Verstegen, Luc J.W. Laan, Jeroen Jonge – 21 July 2020
Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics
Lynn E. Taylor – 21 July 2020
State of the Hepatitis C Virus Care Cascade
David L. Thomas – 21 July 2020
Management of Hepatitis C–Infected Patients After Sustained Virological Response
Brian Pearlman – 21 July 2020
Management of Hepatitis C–Infected Patients After Sustained Virological Response
Brian Pearlman – 21 July 2020
Introduction to Innovations in Hepatitis Elimination
John W. Ward – 21 July 2020
Introduction to Innovations in Hepatitis Elimination
John W. Ward – 21 July 2020
Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity
Joud Arnouk, Vikrant P. Rachakonda, Diana Jaiyeola, Jaideep Behari – 21 July 2020 – Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity. The prevalence of extreme obesity, defined as body mass index (BMI) of 50 kg/m2 or higher, is rising more rapidly than overall obesity. We aimed to compare the clinical outcomes and performance of noninvasive fibrosis assessment tools in NAFLD with or without extreme obesity.